PIGP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.676600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.461600E-02
Normal-vs-Stage2
4.179400E-01
Normal-vs-Stage3
6.220800E-01
Normal-vs-Stage4
5.489400E-01
Stage1-vs-Stage2
8.218200E-03
Stage1-vs-Stage3
6.867700E-02
Stage1-vs-Stage4
8.314300E-02
Stage2-vs-Stage3
7.072000E-01
Stage2-vs-Stage4
8.108600E-01
Stage3-vs-Stage4
9.166200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.921000E-01
Normal-vs-AfricanAmerican
2.433200E-01
Normal-vs-Asian
1.373220E-01
Caucasian-vs-AfricanAmerican
5.185400E-01
Caucasian-vs-Asian
6.300800E-01
AfricanAmerican-vs-Asian
8.531200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.373600E-01
Normal-vs-Female
2.928400E-01
Male-vs-Female
5.294200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.903800E-01
Normal-vs-Age(41-60Yrs)
1.767170E-01
Normal-vs-Age(61-80Yrs)
4.807400E-01
Normal-vs-Age(81-100Yrs)
3.538400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.898000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.342000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.471000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.878400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.670400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.256600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.401600E-02
Normal-vs-Daily Drinker
5.549800E-01
Normal-vs-Weekly Drinker
8.297400E-01
Normal-vs-Occasional Drinker
1.276100E-02
Normal-vs-Social Drinker
4.650600E-01
Non Drinker-vs-Daily Drinker
4.184600E-01
Non Drinker-vs-Weekly Drinker
2.206800E-01
Non Drinker-vs-Occasional Drinker
3.048600E-01
Non Drinker-vs-Social Drinker
8.368800E-01
Daily Drinker-vs-Weekly Drinker
4.775800E-01
Daily Drinker-vs-Occasional Drinker
8.942300E-02
Daily Drinker-vs-Social Drinker
5.835600E-01
Weekly Drinker-vs-Occasional Drinker
3.416200E-02
Weekly Drinker-vs-Social Drinker
2.891800E-01
Occasional Drinker-vs-Social Drinker
2.768600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.954030E-01
Normal-vs-Grade 2
1.077810E-01
Normal-vs-Grade 3
7.680300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.064400E-01
Grade 1-vs-Grade 3
1.286950E-01
Grade 1-vs-Grade 4
1.954030E-01
Grade 2-vs-Grade 3
5.861800E-01
Grade 2-vs-Grade 4
1.077810E-01
Grade 3-vs-Grade 4
7.680300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.884400E-02
Normal-vs-NonDiabetic
3.683000E-01
Diabetic-vs-NonDiabetic
4.000400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.210800E-01
Normal-vs-NoPancreatitis
4.093600E-01
Pancreatitis-vs-NoPancreatitis
9.443200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.412800E-04
Normal-vs-N1
4.347000E-01
N0-vs-N1
1.546290E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.690410E-02
Normal-vs-TP53-NonMutant
1.817580E-03
TP53-Mutant-vs-TP53-NonMutant
2.251600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
